Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Molecular Medicine (Berlin, Germany)|June 13, 2008
Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathyHenry Fechner, Isaac Sipo, Dirk Westermann, et al.
Molecular Therapy. Oncology|August 4, 2026
Arming oncolytic Coxsackievirus B3 with Neoleukin-2/15 enhances growth inhibition of colorectal carcinomas and induces T cell activationLeslie Elsner, Maxim Girod, Ahmet Hazini, et al.
Circulation|February 20, 2003
Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanismHenry Fechner, Michel Noutsias, Carsten Tschoepe, et al.
Human Gene Therapy|January 22, 2021
miR-375- and miR-1-Regulated Coxsackievirus B3 Has No Pancreas and Heart Toxicity But Strong Antitumor Efficiency in Colorectal CarcinomasAhmet Hazini, Babette Dieringer, Markian Pryshliak, et al.
Stem Cells Translational Medicine|March 20, 2025
Mitigating murine acute and chronic Coxsackievirus B3-induced myocarditis with human right atrial appendage-derived stromal cellsMuhammad El-Shafeey, Kathleen Pappritz, Isabel Voss, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian HamstersKatrin Schaar, Anja Geisler, Milena Kraus, et al.
Basic Research in Cardiology|May 29, 2026
Dissecting myocardial and systemic drivers of cardiac dysfunction in the murine CVB3 myocarditis model using microRNA-guided viral detargetingSarah Ochs, Sandra Pinkert, Sophia Borowski, et al.
International Journal of Molecular Sciences|October 17, 2018
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction StudiesThomas Hiller, Johanna Berg, Laura Elomaa, et al.
Circulation. Heart Failure|September 16, 2017
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced MyocarditisCarsten Tschöpe, Irene Müller, Yu Xia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2018
Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditisKathleen Pappritz, Konstantinos Savvatis, Kapka Miteva, et al.
Pageof 8